Complete Filing Data
Eureka Acquisition Corp reported Stockholders Equity of $19.7 thousand for FY2023.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Eureka Acquisition Corp did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 |
|---|---|---|
| Net Income Loss | $1.4M | $255.7K |
| Operating Income Loss | -$859.7K | -$354.1K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|
| Net Income Loss | -$118.3K | $354.4K | $407.9K | $542.0K | -$29.3K | -$27.1K | -$56.8K | -$5.3K | -$4.0K |
| Operating Income Loss | -$417.6K | -$251.4K | -$186.7K | -$152.0K | -$29.3K | -$27.1K | -$56.8K | -$5.3K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Stockholders Equity | $19.7K | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | |||
| Liabilities Current | $49.7K | $264.4K | |
| Liabilities And Stockholders Equity | $58.8M | $284.1K | |
| Liabilities | $49.7K | $264.4K | |
| Assets Current | $734.2K | $47.2K | |
| Assets | $58.8M | $284.1K | |
| Accounts Payable And Accrued Liabilities Current | $39.7K | $160.4K | |
| Retained Earnings Accumulated Deficit | $250.4K | -$5.3K | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -$618.9K | $670.4K | |
| Temporary Equity Carrying Amount Attributable To Parent | $55.9M | ||
| Assets Held In Trust Noncurrent | $58.1M | ||
| Temporary Equity Accretion To Redemption Value | $4.4M | $1.2M | |
| Gain On Sale Of Investments | $2.2M | $609.8K | |
| Reversal Of Deferred Offering Cost Being Waived | -$100.0K | ||
| Deferred Costs | $236.9K | ||
| Repayments Of Related Party Debt | $1.1K | ||
| Repayments Of Notes Payable | $481.5K | ||
| Deferred Offering Costs Paid Via Promissory Note Related Party | |||
| Deferred Offering Costs Included In Accrued Offering Costs | |||
| Public Shareholder Redemption Payable | |||
| Deferred Offering Costs Paid By Sponsor In Exchange For Issuance Of Class B Ordinary Shares | |||
| Cash Equivalents At Carrying Value |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | -$1.5M | -$625.3K | $148.6K | $1.1M | $2.0M | $2.9M | -$93.6K | -$64.2K | -$37.1K | $21.0K | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $32.8K | $51.4K | $274.2K | $354.8K | $552.0K | $670.4K | $57.9K | $36.3K | $13.0K | ||
| Liabilities Current | $1.5M | $724.6K | $29.7M | $87.0K | $57.5K | $383.2K | |||||
| Liabilities And Stockholders Equity | $32.1M | $31.4M | $60.3M | $59.8M | $59.4M | $289.7K | |||||
| Liabilities | $1.5M | $724.6K | $29.7M | $87.0K | $57.5K | $383.2K | |||||
| Assets Current | $32.8K | $99.3K | $317.8K | $432.7K | $589.9K | $65.4K | |||||
| Assets | $32.1M | $31.4M | $60.3M | $59.8M | $59.4M | $289.7K | |||||
| Accounts Payable And Accrued Liabilities Current | $345.7K | $174.6K | $203.4K | $77.0K | $47.5K | $13.2K | |||||
| Retained Earnings Accumulated Deficit | -$1.5M | -$625.5K | $1.1M | $792.4K | -$118.6K | ||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -$18.6K | -$118.3K | $13.0K | ||||||||
| Temporary Equity Carrying Amount Attributable To Parent | $32.1M | $31.3M | $30.5M | $58.6M | $57.3M | ||||||
| Assets Held In Trust Noncurrent | $32.1M | $31.3M | $60.0M | $59.4M | $58.8M | ||||||
| Temporary Equity Accretion To Redemption Value | $1.3M | $1.3M | $1.4M | ||||||||
| Gain On Sale Of Investments | $299.4K | $605.7K | $694.1K | ||||||||
| Reversal Of Deferred Offering Cost Being Waived | $159.4K | ||||||||||
| Deferred Costs | $224.3K | ||||||||||
| Repayments Of Related Party Debt | |||||||||||
| Repayments Of Notes Payable | |||||||||||
| Deferred Offering Costs Paid Via Promissory Note Related Party | $52.5K | ||||||||||
| Deferred Offering Costs Included In Accrued Offering Costs | $25.0K | ||||||||||
| Public Shareholder Redemption Payable | $29.5M | ||||||||||
| Deferred Offering Costs Paid By Sponsor In Exchange For Issuance Of Class B Ordinary Shares | 25.0K | ||||||||||
| Cash Equivalents At Carrying Value | $57.9K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 |
|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$668.9K | -$282.5K |
| Increase Decrease In Accounts Payable And Accrued Liabilities | $134.9K | $39.7K |
| Increase Decrease In Prepaid Expense | -$16.0K | $16.6K |
| Net Cash Provided By Used In Financing Activities | -$29.0M | $58.5M |
| Proceeds From Notes Payable | $500.0K | $377.5K |
| Payments Of Stock Issuance Costs | $359.6K | |
| Net Cash Provided By Used In Investing Activities | $29.0M | -$57.5M |
| Increase Decrease In Due To Related Parties | $40.0K | $10.0K |
| Proceeds From Issuance Initial Public Offering | $57.5M | |
| Share Based Compensation | $38.5K | |
| Proceeds From Related Party Debt | $377.5K | |
| Proceeds From Issuance Of Private Placement | $2.3M | |
| Payments To Acquire Investments | $57.5M | |
| Payments To Acquire Assets Investing Activities | $450.0K | |
| Proceeds From Sale Of Private Placement Units | $2.3M | |
| Proceeds From Repayments Of Related Party Debt | ||
| Proceeds From Decommissioning Fund | $29.5M | |
| Proceeds From Debt Net Of Issuance Costs | $45.9K | |
| Payments For Repurchase Of Equity | $29.5M | |
| Increase Decrease In Due To Other Related Parties Current | $10.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q4 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$168.6K | -$118.3K | -$77.9K | -$4.3K |
| Increase Decrease In Accounts Payable And Accrued Liabilities | $171.1K | $7.8K | -$59.4K | $1.1K |
| Increase Decrease In Prepaid Expense | -$47.9K | -$25.9K | -$38.3K | |
| Net Cash Provided By Used In Financing Activities | $600.0K | $91.0K | $4.3K | |
| Proceeds From Notes Payable | $550.0K | $125.0K | ||
| Payments Of Stock Issuance Costs | $34.0K | |||
| Net Cash Provided By Used In Investing Activities | -$450.0K | |||
| Increase Decrease In Due To Related Parties | $30.0K | |||
| Proceeds From Issuance Initial Public Offering | ||||
| Share Based Compensation | ||||
| Proceeds From Related Party Debt | $50.0K | |||
| Proceeds From Issuance Of Private Placement | ||||
| Payments To Acquire Investments | ||||
| Payments To Acquire Assets Investing Activities | $450.0K | |||
| Proceeds From Sale Of Private Placement Units | ||||
| Proceeds From Repayments Of Related Party Debt | $4.3K | |||
| Proceeds From Decommissioning Fund | ||||
| Proceeds From Debt Net Of Issuance Costs | ||||
| Payments For Repurchase Of Equity | ||||
| Increase Decrease In Due To Other Related Parties Current |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 |
|---|---|---|
| Preferred Stock Shares Authorized | 10.0M | 10.0M |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Prepaid Expense Current | $63.8K | $47.2K | |
| Additional Paid In Capital | $2.6M | $24.9K | |
| Accretions Of Carrying Value To Redemption Value | $4.4M | $1.2M | |
| Investment Income Interest And Dividend | |||
| Investment Income Interest | $2.2M | $609.8K | |
| Stock Issued During Period Value New Issues | $301.3K | ||
| Operating Costs And Expenses | |||
| Payment Of Underwriter Commissions | -$862.5K | ||
| Payment Of Financing And Stock Issuance Costs | $359.6K | ||
| Accretion Of Carrying Value To Redemption Value | $1.2M | ||
| Transfer Class B Shares To Independent Directors | 38.5K | ||
| Term Extension Fee | |||
| Subsequent Measurement Of Ordinary Shares Subject To Redemptioninterest Earned On Trust Acco | |||
| Stock Issued During Period Value Issued For Services | $38.5K | ||
| Stock Issued During Period Value Issued For Representative Shares | 301.3K | ||
| Stock Issued During Period Value Issuance Of Public Rights Net Of Issuance Cost | $1.2M | ||
| Stock Issued During Period Value Issuance Of Private Placement Units | $2.3M | ||
| Reversal Of Offering Costs Being Waived | -$100.0K | ||
| Prepaid Expenses Paid Via Promissory Note Related Party | |||
| Extension Fees Deposited Into Trust Account Extension Fees Deposited Into Trust Account | $450.0K | ||
| Adjustments To Additional Paid In Capital Stock Issued Issuance Costs | $1.2M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q2 2024 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|
| Prepaid Expense Current | $47.9K | $43.6K | $78.0K | $37.9K | $7.5K | |||
| Additional Paid In Capital | $1.2M | $24.9K | ||||||
| Accretions Of Carrying Value To Redemption Value | $749.4K | $1.4M | ||||||
| Investment Income Interest And Dividend | $605.7K | $594.6K | $694.1K | |||||
| Investment Income Interest | $299.4K | $694.1K | ||||||
| Stock Issued During Period Value New Issues | $25.0K | $25.0K | ||||||
| Operating Costs And Expenses | $29.3K | $4.0K | ||||||
| Payment Of Underwriter Commissions | ||||||||
| Payment Of Financing And Stock Issuance Costs | ||||||||
| Accretion Of Carrying Value To Redemption Value | $1.4M | |||||||
| Transfer Class B Shares To Independent Directors | ||||||||
| Term Extension Fee | -$450.0K | |||||||
| Subsequent Measurement Of Ordinary Shares Subject To Redemptioninterest Earned On Trust Acco | -299.4K | |||||||
| Stock Issued During Period Value Issued For Services | ||||||||
| Stock Issued During Period Value Issued For Representative Shares | ||||||||
| Stock Issued During Period Value Issuance Of Public Rights Net Of Issuance Cost | ||||||||
| Stock Issued During Period Value Issuance Of Private Placement Units | ||||||||
| Reversal Of Offering Costs Being Waived | ||||||||
| Prepaid Expenses Paid Via Promissory Note Related Party | $47.2K | |||||||
| Extension Fees Deposited Into Trust Account Extension Fees Deposited Into Trust Account | ||||||||
| Adjustments To Additional Paid In Capital Stock Issued Issuance Costs |
Most recent annual filing with the SEC: December 15, 2025
Data sourced from SEC EDGAR public filings as of August 4, 2026.